Circulation:肌联蛋白截短突变与先天性扩张型心肌病

2019-07-06 MedSci MedSci原创

Titin基因截断变异(TTNtvs)在先天性扩张型心肌病(DCM)患者中很常见。但还没有对TTNtvs在不同临床环境中的影响进行全面的基因组学评估,也无修饰因子评估。Haggerty 等人对71000位(61040位来自Geisinger研究,10273位来自PennMedicine BioBank研究)个体的全外显子测序数据进行回顾性分析,筛选携带TTNtvs的患者,并进一步选择突变高表达的外

Titin基因截断变异(TTNtvs)在先天性扩张型心肌病(DCM)患者中很常见。但还没有对TTNtvs在不同临床环境中的影响进行全面的基因组学评估,也无修饰因子评估。

Haggerty 等人对71000位(61040位来自Geisinger研究,10273位来自PennMedicine BioBank研究)个体的全外显子测序数据进行回顾性分析,筛选携带TTNtvs的患者,并进一步选择突变高表达的外显子上的个体。结合病历,评估TTNtvs与诊断和超声检查的相关性。

PennMedicine BioBank和Geisinger分别有1.2%和0.6%的个体在高表达的外显子(hiPSI)上携带肌联蛋白截短突变(TTNtvs)。hiPSI-TTNtvs的出现与欧洲人患DCM的风险增加相关(PennMedicine BioBank:OR 18.7 [95% CI 9.1-39.4];Geisinger:10.8 [7.0–16.0])。hiPSI-TTNtvs与非洲人患DCM的风险无关(OR 1.8[0.2-13.7])。对于PennMedicine BioBank研究中的244位欧洲人DCM患者,携带hiPSI-TTNtvs的患者左心室射血分数更低,左心室直径增大。在Geisinger研究中,无心肌病的hiPSI-TTNtvs携带者房颤心衰和左心室射血分数降低的发生率更高。

无论心肌病的临床表现如何,携带hiPSI-TTNtvs的欧洲人具有以左室射血分数降低为特征的异常心脏表型。此外,还观察到hiPSI TTNtv 与心律失常(包括房颤)存在一定相关性。但在非洲人中没有发现hiPSI TTNtvs和DCM之间具有相关性。本研究结果或可提高HiPSI TTNtv携带者的临床鉴定和治疗管理

原始出处:

Christopher M. Haggerty,et al. Genomics-First Evaluation of Heart Disease Associated With Titin-Truncating Variants. https://doi.org/10.1161/CIRCULATIONAHA.119.039573Circulation. 2019;140:42–54

本文系梅斯医学(MedSci)原创编译,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1736330, encodeId=7bd71e363304d, content=<a href='/topic/show?id=036c541e929' target=_blank style='color:#2F92EE;'>#截短突变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54179, encryptionId=036c541e929, topicName=截短突变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f634126192, createdName=xiaoyang_ambs, createdTime=Sat Jul 20 15:28:00 CST 2019, time=2019-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636076, encodeId=941316360e69e, content=<a href='/topic/show?id=ac168096935' target=_blank style='color:#2F92EE;'>#肌联蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80969, encryptionId=ac168096935, topicName=肌联蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=465c22580188, createdName=ms4964546379600229, createdTime=Thu Feb 06 19:28:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684799, encodeId=8c051684e99b6, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Mon Aug 19 18:28:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369457, encodeId=1f30136945e1a, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Mon Jul 08 12:28:00 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622397, encodeId=f471162239ed7, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Jul 08 12:28:00 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369187, encodeId=5e1636918ec8, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Sat Jul 06 23:09:50 CST 2019, time=2019-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369184, encodeId=cdb63691844d, content=这种概率算是大还是小,怎么算的?有没有一个比较,真的意义吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4cca2757578, createdName=940880420, createdTime=Sat Jul 06 22:49:17 CST 2019, time=2019-07-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1736330, encodeId=7bd71e363304d, content=<a href='/topic/show?id=036c541e929' target=_blank style='color:#2F92EE;'>#截短突变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54179, encryptionId=036c541e929, topicName=截短突变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f634126192, createdName=xiaoyang_ambs, createdTime=Sat Jul 20 15:28:00 CST 2019, time=2019-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636076, encodeId=941316360e69e, content=<a href='/topic/show?id=ac168096935' target=_blank style='color:#2F92EE;'>#肌联蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80969, encryptionId=ac168096935, topicName=肌联蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=465c22580188, createdName=ms4964546379600229, createdTime=Thu Feb 06 19:28:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684799, encodeId=8c051684e99b6, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Mon Aug 19 18:28:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369457, encodeId=1f30136945e1a, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Mon Jul 08 12:28:00 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622397, encodeId=f471162239ed7, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Jul 08 12:28:00 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369187, encodeId=5e1636918ec8, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Sat Jul 06 23:09:50 CST 2019, time=2019-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369184, encodeId=cdb63691844d, content=这种概率算是大还是小,怎么算的?有没有一个比较,真的意义吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4cca2757578, createdName=940880420, createdTime=Sat Jul 06 22:49:17 CST 2019, time=2019-07-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1736330, encodeId=7bd71e363304d, content=<a href='/topic/show?id=036c541e929' target=_blank style='color:#2F92EE;'>#截短突变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54179, encryptionId=036c541e929, topicName=截短突变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f634126192, createdName=xiaoyang_ambs, createdTime=Sat Jul 20 15:28:00 CST 2019, time=2019-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636076, encodeId=941316360e69e, content=<a href='/topic/show?id=ac168096935' target=_blank style='color:#2F92EE;'>#肌联蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80969, encryptionId=ac168096935, topicName=肌联蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=465c22580188, createdName=ms4964546379600229, createdTime=Thu Feb 06 19:28:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684799, encodeId=8c051684e99b6, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Mon Aug 19 18:28:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369457, encodeId=1f30136945e1a, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Mon Jul 08 12:28:00 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622397, encodeId=f471162239ed7, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Jul 08 12:28:00 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369187, encodeId=5e1636918ec8, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Sat Jul 06 23:09:50 CST 2019, time=2019-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369184, encodeId=cdb63691844d, content=这种概率算是大还是小,怎么算的?有没有一个比较,真的意义吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4cca2757578, createdName=940880420, createdTime=Sat Jul 06 22:49:17 CST 2019, time=2019-07-06, status=1, ipAttribution=)]
    2019-08-19 lsj637
  4. [GetPortalCommentsPageByObjectIdResponse(id=1736330, encodeId=7bd71e363304d, content=<a href='/topic/show?id=036c541e929' target=_blank style='color:#2F92EE;'>#截短突变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54179, encryptionId=036c541e929, topicName=截短突变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f634126192, createdName=xiaoyang_ambs, createdTime=Sat Jul 20 15:28:00 CST 2019, time=2019-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636076, encodeId=941316360e69e, content=<a href='/topic/show?id=ac168096935' target=_blank style='color:#2F92EE;'>#肌联蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80969, encryptionId=ac168096935, topicName=肌联蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=465c22580188, createdName=ms4964546379600229, createdTime=Thu Feb 06 19:28:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684799, encodeId=8c051684e99b6, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Mon Aug 19 18:28:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369457, encodeId=1f30136945e1a, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Mon Jul 08 12:28:00 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622397, encodeId=f471162239ed7, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Jul 08 12:28:00 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369187, encodeId=5e1636918ec8, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Sat Jul 06 23:09:50 CST 2019, time=2019-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369184, encodeId=cdb63691844d, content=这种概率算是大还是小,怎么算的?有没有一个比较,真的意义吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4cca2757578, createdName=940880420, createdTime=Sat Jul 06 22:49:17 CST 2019, time=2019-07-06, status=1, ipAttribution=)]
    2019-07-08 huirong
  5. [GetPortalCommentsPageByObjectIdResponse(id=1736330, encodeId=7bd71e363304d, content=<a href='/topic/show?id=036c541e929' target=_blank style='color:#2F92EE;'>#截短突变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54179, encryptionId=036c541e929, topicName=截短突变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f634126192, createdName=xiaoyang_ambs, createdTime=Sat Jul 20 15:28:00 CST 2019, time=2019-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636076, encodeId=941316360e69e, content=<a href='/topic/show?id=ac168096935' target=_blank style='color:#2F92EE;'>#肌联蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80969, encryptionId=ac168096935, topicName=肌联蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=465c22580188, createdName=ms4964546379600229, createdTime=Thu Feb 06 19:28:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684799, encodeId=8c051684e99b6, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Mon Aug 19 18:28:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369457, encodeId=1f30136945e1a, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Mon Jul 08 12:28:00 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622397, encodeId=f471162239ed7, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Jul 08 12:28:00 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369187, encodeId=5e1636918ec8, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Sat Jul 06 23:09:50 CST 2019, time=2019-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369184, encodeId=cdb63691844d, content=这种概率算是大还是小,怎么算的?有没有一个比较,真的意义吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4cca2757578, createdName=940880420, createdTime=Sat Jul 06 22:49:17 CST 2019, time=2019-07-06, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1736330, encodeId=7bd71e363304d, content=<a href='/topic/show?id=036c541e929' target=_blank style='color:#2F92EE;'>#截短突变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54179, encryptionId=036c541e929, topicName=截短突变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f634126192, createdName=xiaoyang_ambs, createdTime=Sat Jul 20 15:28:00 CST 2019, time=2019-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636076, encodeId=941316360e69e, content=<a href='/topic/show?id=ac168096935' target=_blank style='color:#2F92EE;'>#肌联蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80969, encryptionId=ac168096935, topicName=肌联蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=465c22580188, createdName=ms4964546379600229, createdTime=Thu Feb 06 19:28:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684799, encodeId=8c051684e99b6, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Mon Aug 19 18:28:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369457, encodeId=1f30136945e1a, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Mon Jul 08 12:28:00 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622397, encodeId=f471162239ed7, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Jul 08 12:28:00 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369187, encodeId=5e1636918ec8, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Sat Jul 06 23:09:50 CST 2019, time=2019-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369184, encodeId=cdb63691844d, content=这种概率算是大还是小,怎么算的?有没有一个比较,真的意义吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4cca2757578, createdName=940880420, createdTime=Sat Jul 06 22:49:17 CST 2019, time=2019-07-06, status=1, ipAttribution=)]
    2019-07-06 百草

    666

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1736330, encodeId=7bd71e363304d, content=<a href='/topic/show?id=036c541e929' target=_blank style='color:#2F92EE;'>#截短突变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54179, encryptionId=036c541e929, topicName=截短突变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f634126192, createdName=xiaoyang_ambs, createdTime=Sat Jul 20 15:28:00 CST 2019, time=2019-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636076, encodeId=941316360e69e, content=<a href='/topic/show?id=ac168096935' target=_blank style='color:#2F92EE;'>#肌联蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80969, encryptionId=ac168096935, topicName=肌联蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=465c22580188, createdName=ms4964546379600229, createdTime=Thu Feb 06 19:28:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684799, encodeId=8c051684e99b6, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Mon Aug 19 18:28:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369457, encodeId=1f30136945e1a, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Mon Jul 08 12:28:00 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622397, encodeId=f471162239ed7, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Jul 08 12:28:00 CST 2019, time=2019-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369187, encodeId=5e1636918ec8, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Sat Jul 06 23:09:50 CST 2019, time=2019-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369184, encodeId=cdb63691844d, content=这种概率算是大还是小,怎么算的?有没有一个比较,真的意义吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4cca2757578, createdName=940880420, createdTime=Sat Jul 06 22:49:17 CST 2019, time=2019-07-06, status=1, ipAttribution=)]
    2019-07-06 940880420

    这种概率算是大还是小,怎么算的?有没有一个比较,真的意义吗?

    0

相关资讯

Free RadicBiol Med:肌联蛋白的蛋白质羰基化对围产期心肌细胞发育的影响

围产期是怀分娩前后一段非常重要的时期,在围产期适应期间,N2BA肌联蛋白异构体被转换为N2B肌联蛋白异构体,导致心肌细胞被动张力增加。